PACB Pacific Biosciences of California
- 1.645
- -0.025-1.50%
- 1.630
- -0.015-0.91%
Pacific Biosciences of California News
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders
Even though Pacific Biosciences of California, Inc. (NASDAQ:PACB) has fallen by 12% over the past week , insiders who sold US$3.1m worth of stock over the past year have had less luck. Insiders might
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease ResearchMENLO PARK, Calif., June 10, 2024 /PRNewswire/ -- PacBio
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB) in the last three months.The table below summarizes their rec
Express News | Jefferies Initiates Coverage On Pacific Biosciences With Buy Rating, Announces Price Target of $4
Express News | Pacific Biosciences of California Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $4
Reasons to Retain PacBio (PACB) Stock in Your Portfolio
Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on It
Pacific Biosciences of California (PACB) has recently been on Zacks.com's list of the most searched stocks.
NVIDIA, Dell Technologies, Super Micro Computer Among Premarket Gainers' Pack
How Is The Market Feeling About Pacific Biosciences?
Pacific Biosciences's (NYSE:PACB) short percent of float has risen 8.87% since its last report. The company recently reported that it has 52.82 million shares sold short, which is 22.34% of all regula
Pacific Biosciences Is Maintained at Equal-Weight by Morgan Stanley
Pacific Biosciences Is Maintained at Equal-Weight by Morgan Stanley
Express News | Morgan Stanley Maintains Equal-Weight on Pacific Biosciences, Lowers Price Target to $4
Ambry Genetics And PacBio Selected By UCI And GREGoR Consortium To Support Pediatric Mendelian Genomics Research Center Program To Study Rare Diseases
Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing sol
Express News | Ambry Genetics and Pacbio Announce Collaboration to Sequence up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Consortium Selects Leading Genomics Companies to Support Pediatric Mendelian Genomics Research Center ProgramALISO VIEJO, Calif. and MENLO PARK, Calif., May 15, 2024 /PRNewswire/ --Ambry Genetics, a p
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersDelcath Systems (NASDAQ:DCTH) stock rose 33.2% to $7.19 during Tuesday's regular session. The company's market cap stands at $199.8 million. As per the news, the Q1 earnings report came out tod
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining around 20 points on Tuesday.Shares of Sony Group Corporation (NYSE:SONY) rose sharply during Tuesday's session after the company reported better-tha
Pacific Biosciences of California Up Over 24%, on Pace for Largest Percent Increase Since November 2018 -- Data Talk
Pacific Biosciences of California, Inc. ( PACB ) is currently at $2.40, up $0.47 or 24.35% --Would be highest close since April 15, 2024, when it closed at $2.84 --On pace for largest percent increa
Express News | Shares of 'Meme Stocks' and High-short Interest Stocks Are Trading Higher Amid a Renewed Surge in the Space After Popular Retail Trader 'Roaring Kitty' Returned to Social Media
Expert Outlook: Pacific Biosciences Through The Eyes Of 10 Analysts
Pacific Biosciences (NASDAQ:PACB) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below summarizes their recent ratings, sho
Analysis
Price Target
No Data
